
    
      The study objective is to document the patients' survivorship at 10 years and evaluate the
      performances at 3 months, 1, 2, 3, 5, 7 and 10 years post-surgery of the AVANTAGE RELOAD cup.
      Secondary objective is to evaluate the polyethylene wear between E1 and ARCOM.

      500 patients was the enrollment goal with 2 subgroups.

        -  Subgroup 1: prospective and non-controlled to satisfy ODEP (Orthopedic Device Evaluation
           Panel) requirements;

        -  Subgroup 2: randomized and controlled to compare the polyethylene wear between the Arcom
           and the E1 liners.
    
  